Alerts will be sent to your verified email
Verify Email
SAROJA
|
Saroja Pharma Ind
|
Norris Medicines
|
Emmessar Biotech&Nut
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
27.98 % | 25.68 % | 10.99 % |
|
5yr average Equity Multiplier
|
4.23 | -1.27 | 1.23 |
|
5yr Average Asset Turnover Ratio
|
2.66 | 0.6 | 0.25 |
|
5yr Avg Net Profit Margin
|
2.05 % | -27.67 % | 77.44 % |
|
Price to Book
|
0.83 | 0.0 | 1.63 |
|
P/E
|
12.73 | 0.0 | 56.7 |
|
5yr Avg Cash Conversion Cycle
|
72.5 Days | 113.0 Days | 63.13 Days |
|
Inventory Days
|
9.36 Days | 182.62 Days | 54.75 Days |
|
Days Receivable
|
145.45 Days | 77.44 Days | 11.98 Days |
|
Days Payable
|
53.02 Days | 195.35 Days | 169.78 Days |
|
5yr Average Interest Coverage Ratio
|
2.62 | -1.07 | 820.35 |
|
5yr Avg ROCE
|
33.47 % | -18.91 % | 17.27 % |
|
5yr Avg Operating Profit Margin
|
4.85 % | -2.35 % | -130.11 % |
|
5 yr average Debt to Equity
|
1.55 | -1.84 | 0.0 |
|
5yr CAGR Net Profit
|
7.13 % | -24.21 % | -26.08 % |
|
5yr Average Return on Assets
|
5.43 % | -17.47 % | 8.75 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
73.02 % | 34.0 % | 59.53 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | -0.04 % | 1.0 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Saroja Pharma Ind
|
Norris Medicines
|
Emmessar Biotech&Nut
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|